Impaired glycinergic transmission in hyperekplexia: a model of parasomnia overlap disorder.


Journal

Annals of clinical and translational neurology
ISSN: 2328-9503
Titre abrégé: Ann Clin Transl Neurol
Pays: United States
ID NLM: 101623278

Informations de publication

Date de publication:
09 2019
Historique:
received: 29 06 2019
revised: 18 07 2019
accepted: 20 07 2019
pubmed: 9 8 2019
medline: 19 5 2020
entrez: 9 8 2019
Statut: ppublish

Résumé

We report sleep phenotypes and polysomnographic findings in two siblings with a novel homozygous variant of the GLRA1 gene causing hereditary hyperekplexia (HH). Both sisters had startles during wakefulness and sleep, sleep terrors, and one had symptoms of REM sleep behavior disorder (RBD). Frequent startles were found in NREM sleep associated with NREM parasomnias in deep sleep. In REM sleep, both had motor behaviors and increased phasic/tonic muscle activities confirming RBD. Clonazepam improved startles, motor behaviors, and muscle activities in REM sleep. Impaired glycinergic transmission in human HH could be involved in the pathophysiology of RBD and NREM parasomnias.

Identifiants

pubmed: 31392847
doi: 10.1002/acn3.50866
pmc: PMC6764621
doi:

Substances chimiques

GLRA1 protein, human 0
Receptors, Glycine 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1900-1904

Informations de copyright

© 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.

Références

Sleep. 1997 Nov;20(11):972-81
pubmed: 9456462
Ann Neurol. 2018 Feb;83(2):341-351
pubmed: 29360192
J Sleep Res. 2017 Oct;26(5):614-622
pubmed: 28513054
J Sleep Res. 2019 Oct;28(5):e12831
pubmed: 30815913
Nat Rev Neurol. 2018 Aug;14(8):470-481
pubmed: 29959394
Mov Disord. 2010 Oct 15;25(13):2044-51
pubmed: 20818653
J Neurol Sci. 1978 Sep;38(2):207-13
pubmed: 213539
J Neurosci. 2011 May 11;31(19):7111-21
pubmed: 21562273
Nat Commun. 2018 Feb 5;9(1):504
pubmed: 29402935
Sleep Med. 2008 Aug;9(6):697-700
pubmed: 18060836
Lancet Neurol. 2006 Jun;5(6):513-24
pubmed: 16713923
J Neural Transm (Vienna). 2018 Dec;125(12):1877-1883
pubmed: 30182260
J Neurol Sci. 1967 Nov-Dec;5(3):523-42
pubmed: 5235161
Sleep. 2014 Apr 01;37(4):763-73, 773A-773B
pubmed: 24744455
J Sleep Res. 1993 Dec;2(4):224-231
pubmed: 10607098
Nat Rev Dis Primers. 2018 Aug 30;4(1):19
pubmed: 30166532

Auteurs

Régis Lopez (R)

Département de Neurologie, Unité des Troubles du Sommeil, CHU Montpellier, Montpellier, France.
Inserm U1061, Montpellier, France.

François Rivier (F)

Department of Pediatric Neurology, Neuromuscular Diseases Reference Center AOC, CHU Montpellier, France.
PhyMedExp, University of Montpellier, INSERM, CNRS, Montpellier, France.

Jamel Chelly (J)

Service de Diagnostic Génétique, Hôpital Civil de Strasbourg, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
IGBMC, INSERM, CNRS, Université de Strasbourg, Strasbourg, France.

Yves Dauvilliers (Y)

Département de Neurologie, Unité des Troubles du Sommeil, CHU Montpellier, Montpellier, France.
Inserm U1061, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH